Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study) (original ) (raw )Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG)
G. Papaxoinis
Anticancer research, 2009
View PDFchevron_right
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
Timothy Angelotti
Annals of Surgical Oncology
View PDFchevron_right
Treatment Outcomes of Epithelial Ovarian Cancer A Longitudinal Study
Khadijah Abid
Asian Pacific Journal of Cancer Care
View PDFchevron_right
Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian Cancer
Benedetta Guani
Journal of Clinical Medicine
View PDFchevron_right
Epithelial Ovarian Cancer-an Audit of Patients Treated Over 15 Years
Anu Tiwari
Indian Journal of Medical and Paediatric Oncology, 2006
View PDFchevron_right
Management of Ovarian Cancer: Experience of a single Institution
Enas A Elkhouly
Research in Oncology, 2014
View PDFchevron_right
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
Giuseppa Scandurra
Journal of Ovarian Research, 2019
View PDFchevron_right
Real-world clinical practice patterns and outcomes for advanced ovarian cancer in Spain (GEICO-42-R study)
Cesar Mendiola
European Journal of Gynaecological Oncology, 2021
View PDFchevron_right
Actualities in Ovarian Cancer in the Perspective of 2015 (ASCO and ECCO)
Dana-Lucia Stanculeanu
2016
View PDFchevron_right
Current Challenges and Future Directions in the Management of Ovarian Cancer: Proceedings of the First Global Workshop on Ovarian Cancer
Thomas Herzog
Clinical Ovarian Cancer, 2010
View PDFchevron_right
Impact of proper surgical treatment on the survival of patients with epithelial ovary cancer
Ana Paula Drummond
Revista do Colégio Brasileiro de Cirurgiões
View PDFchevron_right
No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands
Roy Kruitwagen
European Journal of Cancer, 2018
View PDFchevron_right
Present optimal therapy in ovarian cancer
Jeffrey Abrams
European Journal of Cancer and Clinical Oncology, 1986
View PDFchevron_right
Clinical trials in patients with epithelial ovarian cancer: past, present and future
S. Pecorelli
European journal of surgical oncology, 1996
View PDFchevron_right
Evolution of Clinical Trials in Ovarian Cancer Management over the Past 20 Years: Never Settle Down, Always Go Beyond
elena giudice
Journal of Oncology
View PDFchevron_right
Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study
Ana Frobe
Journal of Oncology
View PDFchevron_right
Ovarian cancer: Current status and strategies for improving therapeutic outcomes
Maya Nair
Cancer Medicine
View PDFchevron_right
Chemotherapeutic Regimens and Chemotherapy-Free Intervals Influence the Survival of Patients with Recurrent Advanced Epithelial Ovarian Carcinoma: A Retrospective Population-Based Study
Wen-fang Cheng
International Journal of Environmental Research and Public Health
View PDFchevron_right
180 Real-world treatment patterns and outcomes with first-line maintenance olaparib for BRCAm advanced ovarian cancer: a pan-European study (OVAL-1)
Emmanuel Dube
Ovarian cancer, 2021
View PDFchevron_right
Survival after recurrence in early-stage high-risk epithelial ovarian cancer: A Gynecologic Oncology Group study
Thomas Herzog
Gynecologic Oncology, 2010
View PDFchevron_right
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
Nicoletta Colombo , Robert Fruscio
Annals of Oncology, 2013
View PDFchevron_right
GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
C. Mendiola
Clinical and Translational Oncology, 2013
View PDFchevron_right
Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))
Valter Torri
British journal of cancer, 1990
View PDFchevron_right
A retrospective study on ovarian cancer with a median follow-up of 36 months at Bejaïa University Hospital
IJAERS Journal
View PDFchevron_right
Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM)
giovanni aletti
Tumori Journal, 2020
View PDFchevron_right
Survival of Advanced Stage High-Grade Serous Ovarian Cancer Patients in the Republic of Macedonia
Igor Stojkovski
Open access Macedonian journal of medical sciences, 2017
View PDFchevron_right
Ovarian cancer – where are we today?
Bogdan Gaspar
Romanian Journal of Medical Practice
View PDFchevron_right
Optimal treatment of early-stage ovarian cancer
Andrea Alberto Lissoni
Annals of Oncology, 2014
View PDFchevron_right
Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study
Jacob McGee
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018
View PDFchevron_right
Advanced stage mucinous epithelial ovarian cancer: The Hellenic Cooperative Oncology Group experience
Eleni Efstathiou , Dimosthenis Skarlos
Gynecologic Oncology, 2005
View PDFchevron_right
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma
Curt Burger
BJOG: An International Journal of Obstetrics & Gynaecology, 2009
View PDFchevron_right
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference
Kevin Elias
Cancer, 2019
View PDFchevron_right